We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.60 | 9.40 | 9.80 | 9.60 | 9.60 | 9.60 | 111,474 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.44 | 89.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/2/2018 16:28 | C7 your one word response to the granting of the options was "EXCELLENT", would you like to elaborate and explain on what basis is it excellent. | panama7 | |
02/2/2018 16:16 | P7/Loz, tell you the truth my mind is pretty much occupied with other things at the moment. Pretty much told you all my views on that too. Have a good weekend. | chelsea35 | |
02/2/2018 15:53 | C7, you must be delighted with the 22p triggering point for the BOD's options , you'll be able to get all your money back if they achieve such a stretching target after 6 years. I wonder how Inanaco feels about a 22p target in the next 3 years when he has his own £6 target in a matter of months. | panama7 | |
02/2/2018 15:36 | Elsie - The BIG difference here is - that you NOW know - to your cost- that inane'n'co was / were making FALSE CLAIMS HE *KNEW* HE was making FALSE CLAIMS... WHEN HE made them. The WISER, more ASTUTE, more experienced, who avoided the LOSSES, *KNEW* it too. | the real lozan | |
02/2/2018 15:28 | ONW.....been telling you to do exactly that!!! | chelsea35 | |
02/2/2018 15:16 | P 7... Re 13523. One might add that FAR TOO MUCH attention was paid by the trHYPE brigade to 'ALL' those 'jollies' to far-off-places, that were 'heralded' / overstated, that came-to / resulted = in NOTHING of substance. " Doors are open " But.... apparently -'No one was at home' IF those "Doors were open".... WHY is there STILL a NEED to be 'KNOCKING on others'??? | the real lozan | |
02/2/2018 14:58 | C7 Since you say, "Really is a waste of time conversing with you, " I'd be more than delighted if you'd stop doing so. Simply leave me alone and then I guess we'll all be happy, I know I will. :-) Hopefully that will be the end of it. All the best | oldnotwise | |
02/2/2018 14:02 | Loz........hate to tell you, but funding is a reality for every listed share, particularly difficult on AIM. Anyway, I can deal with your posts, something possibly endearing beneath them lol. ATB | chelsea35 | |
02/2/2018 13:35 | RHatton, of course RG is to blame , the data was good enough 5 years ago for RG to tell Investors that he was going to sell the company for 100's of millions. When no one was remotely interested and after raising 8.8m he then told Investors they were now in a position to carry out deals on both platforms. They have since not signed one single commercial deal that has brought in any revenue. He has told Investors several times that Big Pharma want everything for nothing, bearing in mind the Billions that have been spent on deals in the last 5 years, that has to be one of his most ridiculous statements ever. The bloke has mismanaged to a level that is quite incomprehensible and had all the sheep realised earlier how Incompetent he is, as has been pointed out by several Investors we could have benched him long ago. No clear strategy he just fumbled along spouting absolute nonsense that he could never back up with anything of substance. | panama7 | |
02/2/2018 13:29 | ONW.........as ever "I miss the point". ""Your "point" you made to Balerno was made over half an hour AFTER Lozan made the point here!""............. It is very interesting, from my experience, people i have met post very much as they really are, mirror mirror on the wall. Your mind is so devious, you must be very like that yourself. What other points i have missed, you just hate to admit than anybody else might just see what you do too, as you were so indignant to deny on your last jaunt on LSE. Really is a waste of time conversing with you, I hope your superior self acclaimed ego helps get yourself through life. | chelsea35 | |
02/2/2018 11:57 | Tosh - thank you - as you are yours, just don't agree. The oncology vaccine field as you know has been a grave yard for many a company over the last few years. They are undergoing a resurgence (these factors are conveniently brushed aside by many) but they are now being recognized as having a place in the IO revolution that now seems to be taking place. So we agree to differ. | gooosed | |
02/2/2018 11:55 | Could someone explain CLEARLY, what this 'very clever deal" ACTUALLY CONtains ??? It seems MANY people appear to presume - at this moment in time- that SCLP are being ' offered / given' FREE MONEY.... with NO STRINGS ATTACHED . WISER, more ASTUTE folks might ponder-on = What ANY STRINGS might entail - eventually | the real lozan | |
02/2/2018 11:47 | Also though Tosh, is RG to blame or is the data in humans not good enough yet? | rhatton | |
02/2/2018 11:41 | Goosed... show me another deal that RG has done over the last 7 years that even resembles anything like the magnitude of either of these two. Draw your own conclusions, you're absolutely entitled to do so, i'm merely saying that IMHO, these are NOT RG's deals, his track record is abysmal, the share price in testament to that FACT. | tosh 123 | |
02/2/2018 11:32 | Well if you're not sure - smacks of merely fitting to support your constant slating of the guy. | gooosed | |
02/2/2018 11:28 | Tosh all good points. BioNtech too, should a License deal be struck then the SCIB1 investor benefits also. | rhatton | |
02/2/2018 11:25 | Goosed.... so you think that the CRUK deal is an RG deal ???? Really ? No one can be sure, but I bet you that he was NOT the instrumental figure in either of the deals announced. | tosh 123 | |
02/2/2018 11:07 | "RG has left one almighty mess" ? He's delivered "This is a very clever deal" & the potential for a licensing deal on non core Moditope tech. | gooosed | |
02/2/2018 10:54 | Panama, unfortunately the main protagonists no longer work directly for the company. I reiterate my view that RG was pushed. I think the new BOD ( LD aside ) have identified the weakest link, and have done the right thing, but in an honourable manner eg ;- tart it up with a bit of icing sugar by keeping RG in the outfield. In my humble opinion, the restrike of the options is based on reality rather than unrealised daydreams. There is so much work to be done here, and the risks are high. They need to raise money within months just to keep the lights on, if you couple that with the other massive funding requirement, you can see what a huge task they have ahead of them. It is only right for them to share in any upside from here. RG has left one almighty mess and these guys now have to clear it up, with very few tools apart from the IP. IMHO, we need to forget about the RG era, put it down to experience and try to find positives going forward. Unfortunately I don't advocate to the thought that theres a deal sitting in the background waiting to be done. I honestly think that certain members are still out there tying to get someone to finance everything. I think ( hope ) that the two tie ups announced recently should act as a catalyst to being able to sit at a few more tables. In particular the CRUK deal strikes a chord with me and i'll briefly explain why. If you consider the detail of the agreement ( as we know it ), we have the option to buy the resultant data at the end of the trial.... This is a very clever deal. If that data is expected, and it confirms / backs up the current data, then this could be worth many many millions if not Billions, therefore, we now have something that could have a tangible value, so when raising money for other trials, any investor could be offered exposure to the CRUK results, eg ;- they would not only be investing in Scib I, but be able to participate in Scib II via the results from CRUK. I hope that makes sense. | tosh 123 | |
02/2/2018 10:54 | panama7 - fwiw, we don't usually agree but on the question of the options RNS I have to say I was dismayed if for no other reason the IP potential as you say has been increased yet the hurdle price has been lowered to just less than half. Whether it's of any practical consequence or not, we will have to wait and see but imho - it sends out the wrong message. Not an announcement that shouts confidence. | gooosed | |
02/2/2018 10:49 | C7 you miss the point. Even RG has admitted that larger calls should have been made when the share price was buoyant so there's nothing to discuss there! You also seem to miss the point that the market knows what our cash burn is and it can see that if there's not a deal announcement in the near future we're back cap in hand, and I'll bet a fair bit that the share price will move in front of the announced call, so I would be very careful about saying, "yes a placing would need to be done about the £2m level in a maximum of six months, pretty basic stuff." It's certainly not basic with the share price sub 10p which is possible. I don't "Hope" there's a plan, if there isn't it's a dereliction of duty on the BOD's part, so There IS a plan, just what it is nobody (outside of Scancell) should know. Your "point" you made to Balerno was made over half an hour AFTER Lozan made the point here! Glad you agree that the short term here looks potentially distinctly unpleasant.... we agree! I hope (but that's all it can be ATM) that things work out, but I reckon it'll be an uphill struggle for the present. AIMO ATB | oldnotwise | |
02/2/2018 10:36 | ONW and Tosh, I made the very same point to Balerno. A stupid claim to make. As for our fundings has there ever really been a higher share price to tuck away another funding? and no of course at this level it won"t go up. Sorry ONW but it is these points you make inferring others haven"t realised that that still annoy me. Reality for now is we have £4m cash, a cash burn about £333k a month, yes a placing would need to be done about the £2m level in a maximum of six months, pretty basic stuff. What we don"t know is any talks on SCIB1, I rather think after SCIB2 deal there is, and we just don"t know what will occur in that period. I use the word "hopefully", when i say I just hope there is a plan. As i posted yesterday the alternatives look distinctly unpleasant. Have a good day. | chelsea35 | |
02/2/2018 10:07 | Tosh, the question that should be asked is why the BOD have miserably failed to meet their previous option targets and why if the IP has increased exponentially has the Option price decreased exponentially and the targets been made easier. I am waiting for the BOD to rename the Company SCAMCELL as that is exactly what they have spent the last 6 years doing to PI's. | panama7 | |
02/2/2018 09:38 | ONW ;- Precisely... posts crossed. | tosh 123 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions